初次全关节置换术后高危个体因假体周围关节感染手术后延长口服抗生素是否有作用
2018年国际骨科感染共识会议以76%代表(超级多数/强烈共识)中等证据认为,再植入术后针对初始菌种延长口服抗生素3个月可能降低假体周围关节感染导致的失败风险。但延长或长期使用口服抗生素会带来抗生素耐药和副作用(最常见为艰难梭菌相关腹泻)问题,抗生素管理很重要。近期两项研究显示高危患者关节置换术后短期和长期随访中手术部位感染发生率有显著差异且不良反应未显著增加,但另一项研究显示无显著获益;作者认为延长口服抗生素预防可能降低感染率,但仍需更高级别证据验证。
要点
- 2018年国际共识会议76%代表以中等证据达成强烈共识:再植入术后针对初始菌种延长口服抗生素3个月可能降低假体周围关节感染失败风险。
- 延长或长期口服抗生素与抗生素耐药和副作用相关,最常见为艰难梭菌相关腹泻。
- 两项研究显示高危患者关节置换术后手术部位感染发生率有显著差异且不良反应未显著增加,但另一项研究显示无显著获益。
核心结论
- 作者认为在高危初次和翻修髋膝关节置换中使用延长口服抗生素预防可能降低感染率,但仍需更高级别证据(1级)验证该做法,因其潜在不良反应尚不明确。
研究设计与样本
- 本文为对相关研究的汇总讨论,涉及2018年国际骨科感染共识会议以及近期关于高危患者关节置换术后延长口服抗生素预防的研究。
主要发现
- 2018年国际共识会议76%代表(超级多数/强烈共识)以中等证据同意再植入术后针对初始菌种延长口服抗生素3个月可能降低假体周围关节感染导致的失败风险。
- 延长或长期使用口服抗生素会带来抗生素耐药和副作用问题,最常见为艰难梭菌相关腹泻。
- 两项近期研究显示高危患者关节置换术后短期和长期随访中手术部位感染发生率有显著差异,且不良反应未显著增加。
- 另一项研究显示该做法无显著获益。
关键数值与推荐
- 2018年国际共识会议:76%代表(超级多数/强烈共识)、中等证据水平,同意再植入术后针对初始菌种延长口服抗生素3个月可能降低假体周围关节感染失败风险。
临床怎么用
- 作者认为在高危初次和翻修髋膝关节置换中使用延长口服抗生素预防可能降低感染率。
- 作者指出仍需更高级别证据(1级)验证该做法,因其潜在不良反应尚不明确。
- 原文强调抗生素管理在预防和治疗假体周围关节感染中的重要性,以期防止细菌抗生素耐药增加。
局限性
- 作者指出仍需更高级别证据(1级)验证该做法,因其潜在不良反应尚不明确。
- 一项研究显示该做法无显著获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With moderate level of evidence, 76% of delegates (super majority/strong consensus) of the most recent (2018) International Consensus Meeting on orthopedic infections agreed that extended oral antibiotics directed toward initial organisms after reimplantation for 3 months probably reduce the risk of failure due to periprosthetic joint infection. Nevertheless, the use of oral antibiotics becomes increasingly problematic with extended or long-term utilization. The development of antibiotic resistance and side effects are of particular concern, the most common being Clostridium difficile-associated diarrhea. Antibiotic stewardship is important when preventing and treating periprosthetic joint infection to hopefully prevent increase of bacterial antibiotic resistance. Two recent studies showed a significant difference in the incidence of surgical site infections after arthroplasty procedures in high-risk patients during short- and long-term follow-up without significant increase of adverse effects. However, another study showed no significant benefit of this practice. This summary discussed the details of those studies suggesting that the use of extended oral antibiotic prophylaxis in high-risk primary and revision hip and knee arthroplasty may reduce infection rates; nonetheless, additional higher level of evidence (level 1) is still needed to validate this practice as its potential adverse effects are not clear.
引用
- Higuera CA. Is There a Role for Extended Postoperative Oral Antibiotics in Primary Total Joint Arthroplasty High-Risk Individuals After Surgery for Periprosthetic Joint Infection? J Arthroplasty. 2021. PMID: 34942348. doi:10.1016/j.arth.2021.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。